Investigating the potential effects of α-synuclein aggregation on susceptibility to chronic stress in a mouse Parkinson's disease model

被引:2
|
作者
Alwani, Anna [1 ]
Maziarz, Katarzyna [1 ]
Lyszczarz, Gabriela [1 ]
Jankowska-Kieltyka, Monika [1 ]
Roman, Adam [1 ]
Lyszczarz, Gabriela [1 ]
Er, Safak [2 ,3 ]
Barut, Justyna [1 ]
Barczyk-Woznicka, Olga [4 ]
Pyza, Elzbieta [4 ]
Kreiner, Grzegorz [1 ]
Nalepa, Irena [1 ]
Chmielarz, Piotr [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Brain Biochem, Smetna 12, PL-31343 Krakow, Poland
[2] Univ Helsinki, Drug Res Program, Fac Pharm, Helsinki, Finland
[3] Univ Helsinki, HiLIFE, Inst Biotechnol, Helsinki, Finland
[4] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Cell Biol & Imaging, Gronostajowa 9, PL-30387 Krakow, Poland
基金
芬兰科学院;
关键词
alpha-synuclein; Preformed fibrils; Parkinson's disease; Non-motor symptoms; Depression; Chronic stress; LEWY BODIES; DEPRESSIVE-LIKE; AMYGDALA; MICE; BODY; NEURODEGENERATION; COMPENSATION; PHENOTYPES; DEMENTIA; BEHAVIOR;
D O I
10.1007/s43440-023-00530-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Parkinson's disease (PD) is a motor disorder characterized by the degeneration of dopaminergic neurons, putatively due to the accumulation of alpha-synuclein (alpha-syn) in Lewy bodies (LBs) in Substantia Nigra. PD is also associated with the formation of LBs in brain areas responsible for emotional and cognitive regulation such as the amygdala and prefrontal cortex, and concurrent depression prevalence in PD patients. The exact link between dopaminergic cell loss, alpha-syn aggregation, depression, and stress, a major depression risk factor, is unclear. Therefore, we aimed to explore the interplay between sensitivity to chronic stress and alpha-syn aggregation.Methods Bilateral injections of alpha-syn preformed fibrils (PFFs) into the striatum of C57Bl/6 J mice were used to induce alpha-syn aggregation. Three months after injections, animals were exposed to chronic social defeat stress.Results alpha-syn aggregation did not affect stress susceptibility but independently caused increased locomotor activity in the open field test, reduced anxiety in the light-dark box test, and increased active time in the tail suspension test. Ex vivo analysis revealed modest dopaminergic neuron loss in the substantia nigra and reduced dopaminergic innervation in the dorsal striatum in PFFs injected groups. alpha-Syn aggregates were prominent in the amygdala, prefrontal cortex, and substantia nigra, with minimal alpha-syn aggregation in the raphe nuclei and locus coeruleus.Conclusions Progressive bilateral alpha-syn aggregation might lead to compensatory activity increase and alterations in emotionally regulated behavior, without affecting stress susceptibility. Understanding how alpha-syn aggregation and degeneration in specific brain structures contribute to depression and anxiety in PD patients requires further investigation.
引用
收藏
页码:1474 / 1487
页数:14
相关论文
共 50 条
  • [41] Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease
    Patki, Gaurav
    Lau, Yuen-Sum
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 99 (04) : 704 - 711
  • [42] A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease
    Lu, Jia
    Wang, Chenfei
    Cheng, Xin
    Wang, Ruizhi
    Yan, Xuehan
    He, Pengju
    Chen, Hongzhuan
    Yu, Zhihua
    JOURNAL OF NEUROINFLAMMATION, 2022, 19 (01)
  • [43] Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
    Lai, Thuy Thi
    Kim, Yun Joong
    Nguyen, Phuong Thi
    Koh, Young Ho
    Nguyen, Tinh Thi
    Ma, Hyeo-il
    Kim, Young Eun
    FRONTIERS IN INTEGRATIVE NEUROSCIENCE, 2021, 15
  • [44] Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease
    Leem, Yea-Hyun
    Park, Jin-Sun
    Park, Jung-Eun
    Kim, Do-Yeon
    Kang, Jihee Lee
    Kim, Hee-Sun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [45] Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson's disease
    Kim, Sinyeon
    Choi, Jin Gyu
    Kim, Se Woong
    Park, Sang Cheol
    Kang, Yu-ra
    Park, Dong Seok
    Son, Miwon
    Lee, Choong Hwan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 154
  • [46] Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson's Disease
    Gao, Hui-Ming
    Zhang, Feng
    Zhou, Hui
    Kam, Wayneho
    Wilson, Belinda
    Hong, Jau-Shyong
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (06) : 807 - 814
  • [47] α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease
    Tu, Hai-Yue
    Yuan, Bao-Shi
    Hou, Xiao-Ou
    Zhang, Xiao-Jun
    Pei, Chong-Shuang
    Ma, Ya-Ting
    Yang, Ya-Ping
    Fan, Yi
    Qin, Zheng-Hong
    Liu, Chun-Feng
    Hu, Li-Fang
    AGING CELL, 2021, 20 (12)
  • [48] α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections
    Ubeda-Banon, Isabel
    Saiz-Sanchez, Daniel
    de la Rosa-Prieto, Carlos
    Martinez-Marcos, Alino
    BRAIN STRUCTURE & FUNCTION, 2012, 217 (02) : 447 - 458
  • [49] α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling
    Berrocal, Ruben
    Vasquez, Velmarini
    Krs, Sambasiva Rao
    Gadad, Bharathi S.
    Ks, Rao
    MOLECULAR NEUROBIOLOGY, 2015, 51 (03) : 1417 - 1431
  • [50] Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
    Rajagopalan, S
    Andersen, JK
    MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (14) : 1499 - 1510